Kimia Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	1,521	1,114	2,011	2,637	1,538	1,779
Market Cap Growth	-35.38%	-44.60%	-23.72%	71.48%	-13.56%	-0.92%
Enterprise Value	1,861	1,468	2,406	3,205	2,079	2,253
Last Close Price	32.15	23.55	42.51	55.73	32.50	37.60
PE Ratio	19.60	14.99	20.92	-	-	-
PS Ratio	1.32	0.97	1.69	2.51	1.20	1.42
PB Ratio	8.58	6.29	20.18	796.60	28.15	11.95
P/TBV Ratio	14.32	10.49	20.23	908.91	28.59	12.07
P/FCF Ratio	56.70	41.53	12.03	20.24	-	40.28
P/OCF Ratio	14.03	10.28	9.44	18.14	-	22.25
EV/Sales Ratio	1.62	1.28	2.02	3.06	1.62	1.80
EV/EBITDA Ratio	13.04	10.29	11.98	1176.42	-	372.40
EV/EBIT Ratio	17.97	14.18	14.26	-	-	-
EV/FCF Ratio	69.36	54.72	14.40	24.60	-	51.01
Debt / Equity Ratio	1.96	1.96	3.95	149.59	10.66	3.06
Debt / EBITDA Ratio	2.44	2.44	1.95	176.14	-	75.21
Debt / FCF Ratio	12.97	12.97	2.36	3.80	-	10.30
Net Debt / Equity Ratio	1.92	1.92	3.93	149.14	10.62	3.04
Net Debt / EBITDA Ratio	2.38	2.38	1.95	181.23	-19.32	74.77
Net Debt / FCF Ratio	12.66	12.66	2.34	3.79	-6.05	10.24
Asset Turnover	1.07	1.07	1.13	0.95	1.11	1.16
Inventory Turnover	2.31	2.31	2.21	1.94	2.29	3.08
Quick Ratio	0.49	0.49	0.46	0.41	0.41	0.55
Current Ratio	1.04	1.04	0.92	0.88	1.08	1.18
Return on Equity (ROE)	53.70%	53.70%	186.70%	-183.25%	-91.91%	-22.22%
Return on Assets (ROA)	6.04%	6.04%	9.99%	-1.67%	-3.40%	-1.32%
Return on Invested Capital (ROIC)	18.45%	18.05%	24.07%	-5.24%	-10.15%	-3.60%
Return on Capital Employed (ROCE)	24.60%	24.60%	57.40%	-9.70%	-14.00%	-4.80%
Earnings Yield	4.89%	6.67%	4.78%	-2.01%	-6.08%	-2.08%
FCF Yield	1.76%	2.41%	8.31%	4.94%	-6.23%	2.48%
Buyback Yield / Dilution	4.20%	4.20%	-	-	-	-